Evidence map›Paper›PMID 37887605›Full record

ArticleBiomimetics (Basel, Switzerland)2023

Mitotic Nuclei Segmentation and Classification Using Chaotic Butterfly Optimization Algorithm with Deep Learning on Histopathology Images.

Rayed AlGhamdi

Abstract read
In one paragraph

Article in Biomimetics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Rayed AlGhamdiDepartment of Information Technology, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-6277-2124

Funding

King Abdulaziz University IFPIP: 154-611-1443
6 · The paper itself

Abstract

Histopathological grading of the tumors provides insights about the patient's disease conditions, and it also helps in customizing the treatment plans. Mitotic nuclei classification involves the categorization and identification of nuclei in histopathological images based on whether they are undergoing the cell division (mitosis) process or not. This is an essential procedure in several research and medical contexts, especially in diagnosis and prognosis of cancer. Mitotic nuclei classification is a challenging task since the size of the nuclei is too small to observe, while the mitotic figures possess a different appearance as well. Automated calculation of mitotic nuclei is a stimulating one due to their great similarity to non-mitotic nuclei and their heteromorphic appearance. Both Computer Vision (CV) and Machine Learning (ML) approaches are used in the automated identification and the categorization of mitotic nuclei in histopathological images that endure the procedure of cell division (mitosis). With this background, the current research article introduces the mitotic nuclei segmentation and classification using the chaotic butterfly optimization algorithm with deep learning (MNSC-CBOADL) technique. The main objective of the MNSC-CBOADL technique is to perform automated segmentation and the classification of the mitotic nuclei. In the presented MNSC-CBOADL technique, the U-Net model is initially applied for the purpose of segmentation. Additionally, the MNSC-CBOADL technique applies the Xception model for feature vector generation. For the classification process, the MNSC-CBOADL technique employs the deep belief network (DBN) algorithm. In order to enhance the detection performance of the DBN approach, the CBOA is designed for the hyperparameter tuning model. The proposed MNSC-CBOADL system was validated through simulation using the benchmark database. The extensive results confirmed the superior performance of the proposed MNSC-CBOADL system in the classification of mitotic nuclei.

Indexed as

computer-aided diagnosisdeep learningmetaheuristicsmitotic nuclei classificationsegmentation

Identifiers

PMID37887605
PMCPMC10604189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.